Sonnet BioTherapeutics Regains Nasdaq Minimum Bid Price Compliance streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Sonnet BioTherapeutics Holdings Inc. (SONN) will implement a 1-for-22 reverse stock split of its outstanding common stock at the commencement of trading today. In premarket trading today, the stock is up over 2,300% at $4.
Sonnet BioTherapeutics, Inc : Sonnet BioTherapeutics Announces 1-for-22 Reverse Stock Split finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.